**Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group. ***Nasal tumor are independent from lung tumors and have a much shorter latency, therefore their penetrance is calculated on the total mouse number.
CMV
PROMAS DAYS SCLC *IPD *BL *AL *ADC *NL RP-Fgfr1 16GFE125 **72 -- *IPD: intrapulmonary dissemination; BL: bronchial lesions; AL: alveolar lesions; ADC: Adenocarcinoma.; NL: nasal lesions.
**Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group.
***Nasal tumor are independent from lung tumors and have a much shorter latency, therefore their penetrance is calculated on the total mouse number.
PROMAS DAYS SCLC *IPD *BL *AL *ADC *NL RP 16GFE092 **123 -- **Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group.
***Nasal tumor are independent from lung tumors and have a much shorter latency, therefore their penetrance is calculated on the total mouse number. **Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group. ***Nasal tumor are independent from lung tumors and have a much shorter latency, therefore their penetrance is calculated on the total mouse number. **Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group.
***Nasal tumor are independent from lung tumors and have a much shorter latency, therefore their penetrance is calculated on the total mouse number. **Samples depicted in beige indicate mice that died prematurely due to other phenotypes (e.g. nasal tumor) and therefore did not live long enough to develop lung tumors with an expected longer latency such as SCLC. For this reason, we calculated two different penetrance, depicted as well in beige or in white, according to the considered mouse group.
0% 0% 0% 0% ***28,50% 362,27 60% 60% 6,67% 20% 0% RP  16GFE146  184  ------RP  17GFE033  253  -----NA  RP  17GFE034  253  -----NA  RP  17GFE035  253  -----NA  RP  17GFE150 370 RP-Fgfr1 9 **0% **0% 0% 0% 89% 17% 0 % 100% *IPD: intrapulmonary dissemination; BL: bronchial lesions; AL: alveolar lesions; ADC: Adenocarcinoma.; NL: nasal lesions ** RP-Fgfr1 mice were sacrificed earlier than RP mice, due to the presence of huge lesion of LADC; therefore we cannot exclude a late appearance of SCLC. Table S13 . Comparison across a variety of studies of tumor type and location obtained in Trp53 F/F ;Rb1 F/F mouse models by targeting distinct cell types. Related to Figure 7 
